Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

402 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Pancreatic adenocarcinoma.
Ryan DP, Hong TS, Bardeesy N. Ryan DP, et al. N Engl J Med. 2014 Sep 11;371(11):1039-49. doi: 10.1056/NEJMra1404198. N Engl J Med. 2014. PMID: 25207767 Review. No abstract available.
Pancreatic Cancer: Local Success and Distant Failure.
Ryan DP, Grossbard ML. Ryan DP, et al. Oncologist. 1998;3(3):178-188. Oncologist. 1998. PMID: 10388102
Anal carcinoma: histology, staging, epidemiology, treatment.
Ryan DP, Mayer RJ. Ryan DP, et al. Curr Opin Oncol. 2000 Jul;12(4):345-52. doi: 10.1097/00001622-200007000-00011. Curr Opin Oncol. 2000. PMID: 10888420 Review.
A Phase II study of gemcitabine and docetaxel in patients with metastatic pancreatic carcinoma.
Ryan DP, Kulke MH, Fuchs CS, Grossbard ML, Grossman SR, Morgan JA, Earle CC, Shivdasani R, Kim H, Mayer RJ, Clark JW. Ryan DP, et al. Cancer. 2002 Jan 1;94(1):97-103. doi: 10.1002/cncr.10202. Cancer. 2002. PMID: 11815964 Clinical Trial.
Management of locally advanced adenocarcinoma of the pancreas.
Ryan DP, Willett CG. Ryan DP, et al. Hematol Oncol Clin North Am. 2002 Feb;16(1):95-103. doi: 10.1016/s0889-8588(01)00009-0. Hematol Oncol Clin North Am. 2002. PMID: 12063831 Review.
A Phase I study of 9-nitrocamptothecin given concurrently with capecitabine in patients with refractory, metastatic solid tumors.
Michaelson MD, Ryan DP, Fuchs CS, Supko JG, Garcia-Carbonero R, Paul Eder J, Clark JW. Michaelson MD, et al. Among authors: ryan dp. Cancer. 2003 Jan 1;97(1):148-54. doi: 10.1002/cncr.11038. Cancer. 2003. PMID: 12491516 Clinical Trial.
Current perspectives on anal cancer.
Bendell JC, Ryan DP. Bendell JC, et al. Among authors: ryan dp. Oncology (Williston Park). 2003 Apr;17(4):492-7, 502-3; discussion 503, 507-9. Oncology (Williston Park). 2003. PMID: 12735144 Review.
A phase II study of modified deGramont 5-fluorouracil, leucovorin, and oxaliplatin in previously treated patients with metastatic colorectal cancer.
Ryan DP, Clark JW, Kulke MH, Fuchs CS, Earle CC, Enzinger PC, Stuart K, Catarius KJ, Winkelmann J, Mayer RJ. Ryan DP, et al. Cancer Invest. 2003;21(4):505-11. doi: 10.1081/cnv-120022359. Cancer Invest. 2003. PMID: 14533439 Clinical Trial.
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer.
Willett CG, Boucher Y, di Tomaso E, Duda DG, Munn LL, Tong RT, Chung DC, Sahani DV, Kalva SP, Kozin SV, Mino M, Cohen KS, Scadden DT, Hartford AC, Fischman AJ, Clark JW, Ryan DP, Zhu AX, Blaszkowsky LS, Chen HX, Shellito PC, Lauwers GY, Jain RK. Willett CG, et al. Among authors: ryan dp. Nat Med. 2004 Feb;10(2):145-7. doi: 10.1038/nm988. Epub 2004 Jan 25. Nat Med. 2004. PMID: 14745444 Free PMC article. Clinical Trial.
Dihydropyrimidine dehydrogenase and thymidylate synthase polymorphisms and their association with 5-fluorouracil/leucovorin chemotherapy in colorectal cancer.
Zhu AX, Puchalski TA, Stanton VP Jr, Ryan DP, Clark JW, Nesbitt S, Charlat O, Kelly P, Kreconus E, Chabner BA, Supko JG. Zhu AX, et al. Among authors: ryan dp. Clin Colorectal Cancer. 2004 Feb;3(4):225-34. doi: 10.3816/CCC.2004.n.003. Clin Colorectal Cancer. 2004. PMID: 15025795
402 results
Jump to page
Feedback